Robert Gagnon
Director/Board Member at PURPLE BIOTECH LTD
Net worth: 246 832 $ as of 2024-03-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Eric Rowinsky | M | 67 | 14 years | |
James Green | M | 65 | 9 years | |
Dan Paterson | M | 63 | 13 years | |
Gil Efron | M | 57 | 6 years | |
Daniel Calkins | M | 37 | 6 years | |
Peter Smith | M | - |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | - |
Caroline Dorsa | F | 64 | 14 years | |
Brian Stuglik | M | 64 | 7 years | |
Jeffrey Frelick | M | 59 | 9 years | |
Michael Kauffman | M | 60 | 12 years | |
Simcha Rock | M | 73 | 11 years | |
Ido Agmon | M | 46 | 8 years | |
Suzana Nahum Zilberberg | F | 53 | 3 years | |
Katherine Eade | F | 50 | 7 years | |
Thomas Loewald | M | 61 | 7 years | |
Michelle Robertson | F | 57 | 3 years | |
Jeffrey A. Duchemin | M | 58 |
KD Scientific, Inc.
KD Scientific, Inc. Medical SpecialtiesHealth Technology KD Scientific, Inc. provides liquid handling products. It offers syringe pumps, evaporators, concentrators, and accessories. The company was founded on May 02, 1991 and is headquartered in Holliston, MA. | - |
Isaac Israel | M | 44 | 12 years | |
Bruce Stroever | M | 75 | 12 years | |
Stephen Sherwin | M | 75 | 14 years | |
Anil Kapur | M | 54 | 2 years | |
Ori Hershkovitz | M | 49 | 3 years | |
Paul Bunn | M | 79 | 3 years | |
Yael Margolin | M | 70 | 1 years | |
Lior Fhima | M | - | 2 years | |
Michael Schickler | M | 55 | 4 years | |
Cathy Carew | F | - | - | |
Bertrand Loy | M | 58 | 10 years | |
John Johnson | M | 66 | 4 years | |
Siddhesh Angle | M | 39 | - | |
Kristina Burrow | F | - |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | - |
Michael Rome | M | 39 |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | - |
Michael Rome | M | - |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | - |
Ido Morpurgo | M | 51 | 4 years | |
Michael Dambach | M | 57 | 17 years | |
Hagop Youssoufian | M | 67 | 7 years | |
Karin Tollefson | M | 57 | 1 years | |
Yisrael Gewirtz | M | 47 | 8 years | |
Deina Walsh | F | 60 | 10 years | |
William Berlin | M | - | - | |
Scott Biller | M | 68 |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | 4 years |
Jonathan Pachter | M | 66 | 13 years | |
David Mitchell | M | 67 | 1 years | |
Don Hankey | M | 81 | 6 years | |
Leon E. Chen | M | 49 |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | - |
Hadas Reuveni | M | 56 | 7 years | |
Bertrand C. Liang | M | 61 | 4 years | |
J. Goater | M | 48 |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | 1 years |
Matt Patterson | M | 52 |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | 3 years |
Michael Crowther | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert M. Forrester | M | 60 | 8 years | |
Gina Consylman | F | 52 | 7 years | |
Susan M. Luscinski | F | 67 | 28 years | |
Joseph Chiapponi | M | 55 | 6 years | |
Earl Lewis | M | 80 | 18 years | |
Thomas McNaughton | M | 63 | 5 years | |
William Rastetter | M | 75 | 19 years | |
David Green | M | 60 | 21 years | |
James Mullen | M | 65 | 21 years | |
Stelios Papadopoulos | M | 74 | 15 years | |
Alison Lawton | F | 62 | 8 years | |
Lesley Solomon | F | 52 | 2 years | |
Brian Sullivan | M | - | 9 years | |
Samantha Truex | F | - | 8 years | |
George Uveges | M | 76 | 12 years | |
Trevor Anthony Mill | M | 53 | 9 years | |
Richard Mulligan | M | 69 | 14 years | |
Revital Stern-Raff | M | 50 | 4 years | |
Sean Flynn | M | 50 | 1 years | |
John Doyle | M | 46 | 2 years | |
Carlos Costa | M | 51 | 7 years | |
Joseph Mara | M | 49 | - | |
Peter A. Pellegrino | M | 49 | 1 years | |
Madelyn Zeylikman | F | - | - | |
Lynne Sullivan | F | 58 | 10 years | |
Robert A. Hamm | M | 72 | 7 years | |
Eric S. Hoffman | M | 54 | 5 years | |
Timothy Barberich | M | 76 | 8 years | |
Craig Eric Schneier | M | 76 | 8 years | |
Neal J. Harte | M | 79 | 12 years | |
Michael Gilman | M | 69 | 8 years | |
Bruce Wendel | M | 70 | 5 years | |
S. Phanstiel | F | 65 | 6 years | |
Nancy L. Leaming | F | 76 | 14 years | |
Phillip Sharp | M | 79 | 31 years | |
Nir Livneh | M | 45 | - | |
George Scangos | M | 76 | 7 years | |
Brian Posner | M | 62 | 14 years | |
Alexander Denner | M | 54 | 14 years | |
Robert A. Dishman | M | 79 | 15 years | |
Gregory Covino | M | 59 | 6 years | |
Ben Harshbarger | M | 55 | 5 years | |
Marc Schegerin | M | 48 | 4 years | |
Alan Belzer | M | 91 | 10 years | |
Brendan Reidy | M | 46 | 7 years | |
Mary DiBiase | M | 63 | 16 years | |
Michael Panzara | M | 57 | 8 years | |
Cecilia Jones | F | 49 | - | |
Daniel Char | M | 63 | 11 years | |
Mary L. Good | M | 93 | 10 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 84 | 84.00% |
Israel | 17 | 17.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Robert Gagnon
- Personal Network